TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10791216

Group type: EXPERIMENTAL
Intervention: Mannite solution (10%); 2000 mL during the first 2 hours, then 2000 mL per day until no rectal blood observed.
Number of subjects: 39

Group type: COMPARATOR
Intervention: Paromomycine (1 g tid) and lactulose (10 mL tid)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Mannite solution (10%)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Paromomycine and lactulose
Number of subjects: 39
Study: 8876703

Group type: EXPERIMENTAL
Intervention: Atamestane 100 mg
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Atamestane 300 mg
Number of subjects: 292

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 292
Study: 1496141

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy (20 Gy in 10 treatments over 2 weeks)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 176
Study: 6088309

Group type: EXPERIMENTAL
Intervention: Solcoderm
Number of subjects: 0

Group type: COMPARATOR
Intervention: Plain nitric acid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mixture of oxalic and nitric acid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acetic and nitric acid
Number of subjects: 0
Study: 31633643

Group type: EXPERIMENTAL
Intervention: TightRope (1 knotless TightRope)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Screw fixation (two 3.5‐mm cortical positional screws)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: TightRope
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Functional outcomes (Foot and Ankle Disability Index)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Screw fixation
Number of subjects: 103
Study: 29168044

Group type: EXPERIMENTAL
Intervention: Stereotactic radiotherapy (SRT, IRay)
Number of subjects: 468

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 468
Study: 26717873

Group type: EXPERIMENTAL
Intervention: Physician-initiated daily verbal reminders
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nurse-initiated daily verbal reminders
Number of subjects: 0
Study: 24727333

Group type: EXPERIMENTAL
Intervention: Clobetasol propionate 0.05%
Number of subjects: 32

Group type: COMPARATOR
Intervention: Dexamethasone 0.1 mg/mL
Number of subjects: 32
Study: 22113369

Group type: EXPERIMENTAL
Intervention: High-intensity training (n = 24)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (n = 26)
Number of subjects: 50
Study: 21054769

Group type: EXPERIMENTAL
Intervention: 320/25 mg valsartan/hydrochlorothiazide (HCTZ)
Number of subjects: 421

Group type: COMPARATOR
Intervention: 10/25 mg amlodipine/HCTZ
Number of subjects: 421
Study: 17425487

Group type: EXPERIMENTAL
Intervention: Desmoteplase
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (currently approved treatment options)
Number of subjects: 0
Study: 16235865

Group type: EXPERIMENTAL
Intervention: Guided health imagery intervention group
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo-control group
Number of subjects: 71
Study: 12202606

Group type: EXPERIMENTAL
Intervention: Dipstick assay for Brucella-specific immunoglobulin M
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Dipstick assay for typhoid-specific immunoglobulin M
Number of subjects: 85
Study: 10540089

Group type: EXPERIMENTAL
Intervention: Remifentanil with propofol (target plasma concentration of remifentanil varied while maintaining propofol at 4.5 microg x ml-1)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Remifentanil (target concentrations)
Number of subjects: 20
Study: 8529777

Group type: EXPERIMENTAL
Intervention: 100 mg d-alpha-tocopheryl acetate daily
Number of subjects: 161

Group type: COMPARATOR
Intervention: 3 mg d-alpha-tocopheryl acetate daily
Number of subjects: 161
Study: 2160172

Group type: EXPERIMENTAL
Intervention: Essential combined with hemoperfusion
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo combined with hemoperfusion
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Teturam
Number of subjects: 64
Study: 467093

Group type: EXPERIMENTAL
Intervention: Combination of 5-fluorocytosine (1000 mg) and candicidin (5 mg)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Clotrimazole (100 mg)
Number of subjects: 112
Study: 31082898

Group type: EXPERIMENTAL
Intervention: Somatostatin (500 μg bolus followed by 250 μg/h infusion for 5 days)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 28734043

Group type: EXPERIMENTAL
Intervention: Losartan (100 mg/d)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Omega-3 fish oil (2.8 g/d)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Combined losartan and omega-3 fish oil
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 25952309

Group type: EXPERIMENTAL
Intervention: White-Light (WL) colonoscopy
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Narrow-Band Imaging (NBI) colonoscopy
Number of subjects: 159
Study: 22753310

Group type: EXPERIMENTAL
Intervention: Androgen ablation (AA)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Androgen ablation (AA) with chemotherapy
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group (stage- and grade-matched)
Number of subjects: 79
Study: 21730792

Group type: EXPERIMENTAL
Intervention: Silver nylon dressing
Number of subjects: 110

Group type: COMPARATOR
Intervention: Gauze dressing
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (Gauze dressing)
Number of subjects: 110
Study: 19701112

Group type: EXPERIMENTAL
Intervention: Iyengar yoga therapy
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard medical care
Number of subjects: 90
Study: 16954134

Group type: EXPERIMENTAL
Intervention: Intensive statin therapy (atorvastatin 80 mg)
Number of subjects: 978

Group type: COMPARATOR
Intervention: Standard statin therapy (pravastatin 40 mg)
Number of subjects: 978
Study: 14966636

Group type: EXPERIMENTAL
Intervention: Cortisomol sealer+gutta‐percha
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Vitapex+gutta‐percha
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Cortisomol sealer+gutta‐percha after drainage
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Vitapex+gutta‐percha after drainage
Number of subjects: 288
Study: 10631217

Group type: EXPERIMENTAL
Intervention: Femoral vein catheterization
Number of subjects: 124
Study: 8820362

Group type: EXPERIMENTAL
Intervention: Provox VP
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Groningen VP
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Nijdam VP
Number of subjects: 158

Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 158
Study: 1384148

Group type: EXPERIMENTAL
Intervention: BIP regimen (ifosfamide, cisplatin, bleomycin)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 66
Study: 3876325

Group type: EXPERIMENTAL
Intervention: sulphamoxole 3200 mg/trimethoprim 640 mg (single dose)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: trimethoprim 700 mg (single dose)
Number of subjects: 135

Group type: COMPARATOR
Intervention: sulphamoxole 800 mg/trimethoprim 160 mg (twice daily for five days)
Number of subjects: 135
Study: 30052825

Group type: EXPERIMENTAL
Intervention: S66913 (5 mg, 25 mg, or 100 mg orally per day)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 30225880

Group type: EXPERIMENTAL
Intervention: Data provided through the patient portal
Number of subjects: 128

Group type: COMPARATOR
Intervention: Data provided through postal mail
Number of subjects: 128
Study: 26451761

Group type: EXPERIMENTAL
Intervention: EGF
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: bFGF
Number of subjects: 86

Group type: COMPARATOR
Intervention: Observation group
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: EGF and bFGF
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 86
Study: 24594248

Group type: EXPERIMENTAL
Intervention: I-gel
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: ILMA Fastrach
Number of subjects: 45
Study: 23126312

Group type: EXPERIMENTAL
Intervention: Patient directed self management of pain (PaDSMaP)
Number of subjects: 665

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 665

Group type: EXPERIMENTAL
Intervention: PaDSMaP
Number of subjects: 665
Study: 20044066

Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Active smokers
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Self-report vs urine cotinine level
Number of subjects: 315
Study: 18049889

Group type: EXPERIMENTAL
Intervention: GnRH antagonist (ganirelix 0.25 mg/d for 3 days)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control (self-controlled cycle without GnRH antagonist)
Number of subjects: 35
Study: 16260353

Group type: EXPERIMENTAL
Intervention: Nateglinide 120 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 12135593

Group type: EXPERIMENTAL
Intervention: Micronutrient supplementation (beta-carotene, vitamins C and E, zinc, and selenium)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 11461739

Group type: EXPERIMENTAL
Intervention: Home-based intensive training (6 times per week for 3 months)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Routine training (2 times per week for 3 months)
Number of subjects: 62
Study: 9828907

Group type: EXPERIMENTAL
Intervention: Combined therapy with GnRH analogue leuprolide acetate (0.3 mg/kg im every 28 days) and rhGH (0.1 U/kg/day, sc, 6 days a week) for 30.0 ± 5.2 months
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (no therapy)
Number of subjects: 10
Study: 8172436

Group type: EXPERIMENTAL
Intervention: Low-dose radiation (2000 cGy to lymph node areas and 1000 to 1500 cGy to other involved organ sites)
Number of subjects: 278

Group type: COMPARATOR
Intervention: No further treatment
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Low-dose radiation and No further treatment
Number of subjects: 278
Study: 2894764

Group type: EXPERIMENTAL
Intervention: Almitrine bismesylate 50 mg twice a day
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Almitrine bismesylate
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 29567762

Group type: EXPERIMENTAL
Intervention: HHS (Hip-Hop Stroke) intervention
Number of subjects: 3070

Group type: COMPARATOR
Intervention: Attentional control (nutrition classes)
Number of subjects: 3070
Study: 29327548

Group type: EXPERIMENTAL
Intervention: TCM synthetic rehabilitation (manipulative therapy, joint mobilization, soaking-washing with Chinese medicinal herbs, functional exercise)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Functional exercise and soaking-washing with Chinese medicinal herbs (control group)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Grip strength recovery (ipsilateral wrist)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Anxiety levels
Number of subjects: 72
Study: 25531733

Group type: EXPERIMENTAL
Intervention: Tranexamic acid 10 mg/kg as a bolus, 15 minutes before incision
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 0
Study: 24246119

Group type: EXPERIMENTAL
Intervention: Drug therapy change
Number of subjects: 19

Group type: COMPARATOR
Intervention: Standard care (reference group)
Number of subjects: 19
Study: 21177312

Group type: EXPERIMENTAL
Intervention: Single IUI timed at 36 ± 2 h post-hCG (post-ovulation)
Number of subjects: 1146

Group type: COMPARATOR
Intervention: Single IUI timed at 36 ± 2 h post-hCG (pre-ovulation)
Number of subjects: 1146

Group type: EXPERIMENTAL
Intervention: Double IUI in pre-ovulatory cases
Number of subjects: 1146

Group type: COMPARATOR
Intervention: Single IUI in pre-ovulatory cases
Number of subjects: 1146
Study: 19029469

Group type: EXPERIMENTAL
Intervention: Torcetrapib plus atorvastatin
Number of subjects: 1656

Group type: COMPARATOR
Intervention: Atorvastatin alone
Number of subjects: 1656
Study: 17158419

Group type: EXPERIMENTAL
Intervention: High-fructose diet (1.5 g fructose . kg body wt(‐1) . d(‐1) for 4 weeks)
Number of subjects: 7
Study: 14581866

Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 1004

Group type: COMPARATOR
Intervention: HRT
Number of subjects: 1004
Study: 10758964

Group type: EXPERIMENTAL
Intervention: Biventricular pacing (BiV)
Number of subjects: 13
Study: 8828721

Group type: EXPERIMENTAL
Intervention: Viscous carbomer eye drops
Number of subjects: 61

Group type: COMPARATOR
Intervention: 1.4% polyvinyl alcohol‐based (PVA) eye drops
Number of subjects: 61
Study: 1582625

Group type: EXPERIMENTAL
Intervention: Enalapril (E) 20‐40 mg daily
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Calcium Channel Blockers (CCB): slow‐release nifedipine (40 mg) or long‐acting verapamil (120‐360 mg) daily
Number of subjects: 25
Study: 29458318

Group type: EXPERIMENTAL
Intervention: Conservative oxygen therapy
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Standard care oxygen therapy
Number of subjects: 1000
Study: 27251051

Group type: EXPERIMENTAL
Intervention: Daclizumab HYP 150 mg subcutaneous every 4 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interferon beta-1a 30 mcg intramuscular once weekly
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daclizumab HYP
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interferon beta-1a
Number of subjects: 0
Study: 26579947

Group type: EXPERIMENTAL
Intervention: Motor skill training in children with DCD
Number of subjects: 41

Group type: COMPARATOR
Intervention: Nontraining group of children with DCD
Number of subjects: 41

Group type: COMPARATOR
Intervention: Typically developed children (control group)
Number of subjects: 41
Study: 23614998

Group type: EXPERIMENTAL
Intervention: Preexposure prophylaxis (PrEP) with daily tenofovir disoproxil fumarate/emtricitabine
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Availability of PrEP through clinical trial or health insurance
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Perception of PrEP use
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Perception of PrEP on recruitment
Number of subjects: 376
Study: 20092401

Group type: EXPERIMENTAL
Intervention: Vitamin treatment with folic acid and vitamin B12 for 2 months (Group 2, n = 30)
Number of subjects: 59

Group type: COMPARATOR
Intervention: No vitamin treatment (Group 1, n = 29)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Patients with stroke compared to controls (n = 64)
Number of subjects: 59
Study: 19909082

Group type: EXPERIMENTAL
Intervention: Trivalent inactivated split-virus influenza vaccine (TIV)
Number of subjects: 7652

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7652
Study: 16469035

Group type: EXPERIMENTAL
Intervention: Desmopressin (30, 60, 120, 240, 360, or 480 microg)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 15055208

Group type: EXPERIMENTAL
Intervention: Glatiramer
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interferon beta
Number of subjects: 0
Study: 11571068

Group type: EXPERIMENTAL
Intervention: Supportive counselling
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Stress management
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Alcohol‐focused couples therapy
Number of subjects: 61
Study: 9240113

Group type: EXPERIMENTAL
Intervention: Smoking cessation intervention (cognitive-behavioral strategies)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (brief advice)
Number of subjects: 0
Study: 8501751

Group type: EXPERIMENTAL
Intervention: Deflazacort (DFZ)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Prednisone (PRED)
Number of subjects: 34
Study: 2881566

Group type: EXPERIMENTAL
Intervention: Atracurium (ED95 0.23 mg kg‐1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Vecuronium (ED95 0.055 mg kg‐1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no neuromuscular blocking drug)
Number of subjects: 30
Study: 29754015

Group type: EXPERIMENTAL
Intervention: Nurse-led home visit intervention (4 home visits and 4 telephone calls)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard HF management (control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nurse-led home visit intervention
Number of subjects: 0
Study: 27489011

Group type: EXPERIMENTAL
Intervention: DPZS (7 mg Zn/d)
Number of subjects: 7641

Group type: EXPERIMENTAL
Intervention: All supplemented groups
Number of subjects: 7641

Group type: EXPERIMENTAL
Intervention: Preventive and TZS groups
Number of subjects: 7641

Group type: COMPARATOR
Intervention: MSC (morbidity surveillance control)
Number of subjects: 7641
Study: 24787564

Group type: EXPERIMENTAL
Intervention: NAVILAS laser (30 ms pulse duration)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: NAVILAS laser (100 ms pulse duration)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: PASCAL laser (30 ms pulse duration)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: PASCAL laser (100 ms pulse duration)
Number of subjects: 73

Group type: COMPARATOR
Intervention: NAVILAS laser
Number of subjects: 73

Group type: COMPARATOR
Intervention: PASCAL laser
Number of subjects: 73
Study: 22867776

Group type: EXPERIMENTAL
Intervention: Uterine fibroid embolization
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Myomectomy
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Hysterectomy
Number of subjects: 274
Study: 19457494

Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine (40 mL)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.25% levobupivacaine (40 mL)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (0.9% normal saline, 40 mL)
Number of subjects: 60
Study: 19176705

Group type: EXPERIMENTAL
Intervention: Support and instruction for intrinsically motivated women
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Motivational interviewing for extrinsically motivated women
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Minimal breastfeeding counseling for successfully experienced women
Number of subjects: 44
Study: 15836975

Group type: EXPERIMENTAL
Intervention: Mild pressure application
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Moderate pressure application
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Functional MRI during pressure application
Number of subjects: 14

Group type: COMPARATOR
Intervention: Intensity and unpleasantness ratings
Number of subjects: 14

Group type: COMPARATOR
Intervention: Pressure levels (painful or non-painful)
Number of subjects: 14
Study: 12940468

Group type: EXPERIMENTAL
Intervention: Street Smart HIV intervention program
Number of subjects: 187

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 187
Study: 10482044

Group type: EXPERIMENTAL
Intervention: Eukalaemic potassium clamp (potassium supply)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Without potassium supply (decline in potassium monitored)
Number of subjects: 20
Study: 8756273

Group type: EXPERIMENTAL
Intervention: Do-it-yourself method (participants think about how to build the wall and then draw it)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Distance-to-goal evaluation method (participants evaluate how their drawn wall prevents passage)
Number of subjects: 0
Study: 1880318

Group type: EXPERIMENTAL
Intervention: Low-dose methotrexate (MTX)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (folic acid)
Number of subjects: 15
Study: 6179339

Group type: EXPERIMENTAL
Intervention: Cessation of long-term continuous steroid application
Number of subjects: 58
Study: 29617743

Group type: EXPERIMENTAL
Intervention: Head orthosis therapy
Number of subjects: 45

Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: All patients with DP
Number of subjects: 45
Study: 27062690

Group type: EXPERIMENTAL
Intervention: Nurse-led telephone follow-up (TFU)
Number of subjects: 259

Group type: COMPARATOR
Intervention: Hospital follow-up (HFU)
Number of subjects: 259
Study: 24714185

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 699

Group type: COMPARATOR
Intervention: Surgical resection (SR)
Number of subjects: 699
Study: 24199987

Group type: EXPERIMENTAL
Intervention: Female sex
Number of subjects: 1300

Group type: EXPERIMENTAL
Intervention: Fluid intake
Number of subjects: 1300

Group type: EXPERIMENTAL
Intervention: Sodium excretion
Number of subjects: 1300

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 1300

Group type: EXPERIMENTAL
Intervention: Creatinine clearance
Number of subjects: 1300

Group type: EXPERIMENTAL
Intervention: Living in the German-speaking part of Switzerland
Number of subjects: 1300

Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 1300

Group type: EXPERIMENTAL
Intervention: Body mass index
Number of subjects: 1300

Group type: EXPERIMENTAL
Intervention: Current smoking
Number of subjects: 1300

Group type: EXPERIMENTAL
Intervention: Consumption of meat and cold cut
Number of subjects: 1300
Study: 21317148

Group type: EXPERIMENTAL
Intervention: Aliskiren (300 mg)
Number of subjects: 820

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 820
Study: 18789189

Group type: EXPERIMENTAL
Intervention: Body oriented psychological therapy (BPT)
Number of subjects: 0
Study: 18182731

Group type: EXPERIMENTAL
Intervention: Protective ventilation strategy
Number of subjects: 34

Group type: COMPARATOR
Intervention: Traditional ventilation strategy plus PEEP
Number of subjects: 34
Study: 15062138

Group type: EXPERIMENTAL
Intervention: Interstitial pulsed-dose-rate (PDR) brachytherapy (DREF=20-60 Gy)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: All patients treated with interstitial pulsed-dose-rate (PDR) brachytherapy
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Patients treated with curative intention
Number of subjects: 43

Group type: COMPARATOR
Intervention: Chemotherapy or hyperthermia
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Interstitial pulsed-dose-rate (PDR) brachytherapy
Number of subjects: 43
Study: 11032084

Group type: EXPERIMENTAL
Intervention: Reference products as per WHO List of International Comparator Pharmaceutical Products (CPP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Brand products sold locally
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Generic drugs developed using the CPP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phase III clinical studies on products manufactured in a single site
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Formulations with maintained safety and efficacy
Number of subjects: 0